Modalis Therapeutics Corporation (TYO:4883)
90.00
+1.00 (1.12%)
Aug 18, 2025, 9:26 AM JST
Modalis Therapeutics Employees
Modalis Therapeutics had 14 employees as of December 31, 2024. The number of employees decreased by 23 or -62.16% compared to the previous year.
Employees
14
Change (1Y)
-23
Growth (1Y)
-62.16%
Revenue / Employee
n/a
Profits / Employee
-111.24M JPY
Market Cap
6.85B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14 | -23 | -62.16% |
Dec 31, 2023 | 37 | 1 | 2.78% |
Dec 31, 2022 | 36 | 10 | 38.46% |
Dec 31, 2021 | 26 | 6 | 30.00% |
Dec 31, 2020 | 20 | 4 | 25.00% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Chugai Pharmaceutical | 5,026 |
Takeda Pharmaceutical Company | 47,455 |
Daiichi Sankyo Company | 19,765 |
HOYA Corporation | 37,909 |
Otsuka Holdings | 35,338 |
Astellas Pharma | 13,643 |
Shionogi & | 4,955 |
Olympus | 29,297 |
Modalis Therapeutics News
- 2 months ago - SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy - Financial Post